Treatment and Supportive Care

Treating AA amyloidosis requires a dual approach. The central disease-modifying strategy focuses on putting out the inflammatory fire that causes the amyloid to form, while parallel supportive care protects your kidneys and other organs ^[1][2].

By cooling down the underlying inflammation, you stop the liver from overproducing the SAA protein. Lowering SAA removes the “fuel” for new amyloid, which allows your organs to stabilize ^[1][3].

The Goal: Controlling SAA Levels

The most important inflammatory marker in your care is your serum amyloid A (SAA) level. While your doctor will also track C-reactive protein (CRP), SAA is more specific to your risk of developing more amyloid ^[4].

• Common Targets: Many specialists aim to keep your SAA levels below 10 mg/L, though targets can vary by assay and specialist judgment ^[1][5].
• The Outlook: Maintaining a low SAA is associated with better outcomes. In some cases, prolonged control may allow the body to slowly clear some existing amyloid fibrils, though regression is not guaranteed, especially if chronic scarring has already occurred ^[3][6].
• A Warning on CRP: It is possible for your CRP to look normal even while your SAA remains high, particularly if you are taking steroids or certain biologics (like IL-6 inhibitors) that can suppress CRP ^[7].

Condition-Specific Treatments

Your primary treatment depends entirely on which inflammatory “driver” you have.

Familial Mediterranean Fever (FMF)

• Colchicine: This is the cornerstone of treatment for FMF. It is highly effective at preventing amyloidosis when taken consistently ^[8].
• IL-1 Inhibitors: If colchicine doesn’t work or causes too many side effects, doctors may add IL-1 inhibitors like anakinra or canakinumab ^[9]. These drugs block a key inflammatory signal and have been shown to significantly reduce protein in the urine ^[10].

Rheumatic Diseases and Chronic Infections

• Biologics: For certain rheumatic diseases like rheumatoid arthritis, doctors use disease-modifying drugs, often including biologics that target IL-6 or TNF.
• Tocilizumab: This IL-6 inhibitor can be an effective option for selected patients (such as those with RA-associated disease), as it can rapidly lower SAA ^[11][3]. However, it is not a routine default for all conditions (such as IBD) and its choice depends on your infection risk, comorbidities, and local approvals.
• Treating Infections: If your amyloidosis is driven by a chronic infection, treatment must focus on antimicrobial therapy and managing the structural issues causing the infection.

Supportive Organ Care

Because the kidneys are often the most affected organ, controlling inflammation is only one part of the plan. You will likely need supportive care to manage symptoms and protect kidney function.

Supportive Kidney Therapies

• Blood Pressure Control: Medications like ACE inhibitors or ARBs may be used to lower blood pressure and reduce protein loss ^[12].
• Diuretics: These “water pills” help manage edema (swelling) by removing excess fluid.
• Avoiding Harm: Your doctor will review your medications to ensure you avoid nephrotoxic drugs (like NSAIDs) that can further harm the kidneys.
• Thrombosis Risk: Severe nephrotic syndrome can increase your risk of blood clots, so your doctor may evaluate the need for blood thinners.

Advanced Kidney Care

A reduction in proteinuria (such as a 30% drop) is a positive sign, but it must be interpreted alongside your eGFR and albumin levels ^[12]. If amyloid damage is severe enough to cause kidney failure, you may need:

• Dialysis: Both hemodialysis and peritoneal dialysis are options. Controlling your inflammation remains vital during dialysis to protect other organs like your heart and gut ^[13][14].
• Kidney Transplant: A transplant is an option for appropriate candidates. The risk of amyloid returning to the new kidney is generally low as long as the primary disease remains tightly controlled ^[15].